FDA Keeps Door Open To Help Observational Studies Work For Health Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA says in a final guidance that observational studies alone are insufficient support for health claims, but the agency also says it is interested in making it easier for those studies to support claims
You may also be interested in...
FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.
FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.
FDA Veers From Guidance In Some Supplement Health Claim Decisions – Court
FDA made unreasonable demands with disclaimers for proposed qualified health claims for vitamin C and vitamin E to reduce the risk of cancer, according to a court ruling.